Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $8.71 in the prior trading day, ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $8.82, up 1.26%. In other words, the price has increased by $1.26 from its previous closing price. On the day, 0.88 million shares were traded. ORIC stock price reached its highest trading level at $10.33 during the session, while it also had its lowest trading level at $8.725.
Ratios:
Our goal is to gain a better understanding of ORIC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.08 and its Current Ratio is at 15.08. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $20.
On September 22, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $8.Wedbush initiated its Outperform rating on September 22, 2023, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’24 when Chacko Jacob sold 40,000 shares for $16.21 per share. The transaction valued at 648,380 led to the insider holds 728,544 shares of the business.
Chacko Jacob sold 26,042 shares of ORIC for $320,186 on Feb 07 ’24. The PRESIDENT AND CEO now owns 768,544 shares after completing the transaction at $12.29 per share. On Feb 06 ’24, another insider, Chacko Jacob, who serves as the PRESIDENT AND CEO of the company, sold 13,958 shares for $12.12 each. As a result, the insider received 169,160 and left with 794,586 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 622184768 and an Enterprise Value of 345515648.
Stock Price History:
Over the past 52 weeks, ORIC has reached a high of $16.65, while it has fallen to a 52-week low of $5.34. The 50-Day Moving Average of the stock is -10.47%, while the 200-Day Moving Average is calculated to be -13.42%.
Shares Statistics:
The stock has traded on average 442.20K shares per day over the past 3-months and 414660 shares per day over the last 10 days, according to various share statistics. A total of 54.87M shares are outstanding, with a floating share count of 46.01M. Insiders hold about 34.77% of the company’s shares, while institutions hold 65.97% stake in the company. Shares short for ORIC as of 1727654400 were 12262863 with a Short Ratio of 27.73, compared to 1724976000 on 12666065. Therefore, it implies a Short% of Shares Outstanding of 12262863 and a Short% of Float of 17.65.
Earnings Estimates
The firm’s stock currently is rated by 10.0 analysts. The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.44 and low estimates of -$0.53.
Analysts are recommending an EPS of between -$1.71 and -$1.87 for the fiscal current year, implying an average EPS of -$1.81. EPS for the following year is -$2.09, with 10.0 analysts recommending between -$1.95 and -$2.3.
